Fmoc-Cpg-OH

Catalog No.: 
ACFKIV504
CAS No.: 
220497-61-0
Molecular Formula: 
C22H23NO4
Molecular Weight: 
365.43
Fmoc-Cpg-OH structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g98%$58.00In stockInquiry
25g98%$136.00In stockInquiry
100g98%$540.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameFmoc-Cpg-OH
IUPAC Name(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclopentylacetic acid
MDL No.MFCD01311751
Molecular FormulaC22H23NO4
Molecular Weight365.43
SMILESO=C(O)[C@@H](NC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O)C4CCCC4
InChI KeyJGWHUIQSEKGLAQ-FQEVSTJZSA-N
Synonym(2S)-2-cyclopentyl-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)acetic acid | A878776 | Fmoc-(S)-2-Cyclopentylglycine | Fmoc-cyclopentyl-Gly-OH;(S)-2-Cyclopentyl-2-(Fmoc-amino)-acetic acid | CS-W022724 | Fmoc-Gly(cyclopentyl)-OH | N-Fmoc-alpha-cyclopentyl
CAS No.220497-61-0
PubChem CID7006544

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFKIV504 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCEYT167 route compound structure diagram
    ACCEYT1672521-84-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFKIV504 route product structure diagram
    ACFKIV504220497-61-0In Stock
Inquiry

2. ACFKIV504 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFKIV504 route product structure diagram
    ACFKIV504220497-61-0In Stock
Inquiry

3. ACFKIV504 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFKIV504 route product structure diagram
    ACFKIV504220497-61-0In Stock
Inquiry

Comments (0)